Who owns HALOZYME THERAPEUTICS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of HALO from SEC Form 13F filings across 671 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 671 institutions disclosed 123.2M shares of HALOZYME THERAPEUTICS, INC. worth $9.62B — about 105.1% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
671
13F holders
$9.62B
value, 2026 filers
105.1%
of shares outstanding (123.2M sh)
118
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of HALO's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 13.3M | $1.04B | 0.0% | 11.3% | 0.0% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 5.4M | $418.8M | 0.0% | 4.6% | +1.5% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.3M | $414.8M | 0.0% | 4.5% | +0.9% |
| 4 | STATE STREET CORP | 5.2M | $405.4M | 0.0% | 4.4% | +4.9% |
| 5 | Invesco Ltd. | 3.2M | $248.7M | 0.0% | 2.7% | -20.8% |
| 6 | MORGAN STANLEY | 2.8M | $221.7M | 0.0% | 2.4% | +10.5% |
| 7 | Boston Partners | 2.8M | $216.8M | 0.2% | 2.4% | +3.3% |
| 8 | BANK OF AMERICA CORP /DE/ | 2.7M | $214.5M | 0.0% | 2.3% | -5.9% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.5M | $197.3M | 0.0% | 2.1% | +0.6% |
| 10 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2.5M | $196.5M | 0.6% | 2.1% | -0.6% |
| 11 | SNYDER CAPITAL MANAGEMENT L P | 2.4M | $187.5M | 3.2% | 2% | +3.1% |
| 12 | DIMENSIONAL FUND ADVISORS LP | 2.1M | $163.5M | 0.0% | 1.8% | +0.5% |
| 13 | D. E. Shaw & Co., Inc. | 2.0M | $157.0M | 0.1% | 1.7% | +7.4% |
| 14 | LOS ANGELES CAPITAL MANAGEMENT LLC | 1.9M | $151.7M | 0.6% | 1.7% | +180.9% |
| 15 | ROYAL LONDON ASSET MANAGEMENT LTD | 1.8M | $141.7M | 0.3% | 1.5% | +12.4% |
| 16 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.7M | $133.4M | 0.1% | 1.5% | -11.1% |
| 17 | ALLIANCEBERNSTEIN L.P. | 1.7M | $109.6M | 0.0% | 1.4% | -2.3% |
| 18 | TWO SIGMA INVESTMENTS, LP | 1.7M | $129.4M | 0.1% | 1.4% | +4.3% |
| 19 | UBS Group AG | 1.5M | $116.8M | 0.0% | 1.3% | +63.3% |
| 20 | FULLER & THALER ASSET MANAGEMENT, INC. | 1.5M | $116.7M | 0.3% | 1.3% | +1.8% |
| 21 | NORGES BANKNEW | 1.5M | $116.1M | 0.0% | 1.3% | new |
| 22 | FIRST TRUST ADVISORS LP | 1.4M | $110.9M | 0.1% | 1.2% | -4.4% |
| 23 | LSV ASSET MANAGEMENT | 1.4M | $110.4M | 0.2% | 1.2% | +2.8% |
| 24 | Stephens Investment Management Group LLC | 1.4M | $109.0M | 1.2% | 1.2% | +14.3% |
| 25 | WELLS FARGO & COMPANY/MN | 1.4M | $108.8M | 0.0% | 1.2% | -9.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.